A Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI110 in Subjects With Advanced Malignant Tumors
Clinical trial NCT04085185 · UNKNOWN
Trial details
- NCT number
- NCT04085185
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-04
- Primary completion
- 2023-12-15
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.